Literature DB >> 12386044

Venous thromboembolism: pathophysiology, clinical features, and prevention.

Alexander G G Turpie1, Bernard S P Chin, Gregory Y H Lip.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12386044      PMCID： PMC1124386          DOI： 10.1136/bmj.325.7369.887

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  21 in total

1.  Anti-Xa Levels 4 h After Subcutaneous Administration of 5,700 IU Nadroparin Strongly Correlate with Lean Body Weight in Morbidly Obese Patients.

Authors:  Jeroen Diepstraten; Christian M Hackeng; Simone van Kralingen; Jiri Zapletal; Eric P A van Dongen; René J Wiezer; Bert van Ramshorst; Catherijne A J Knibbe
Journal:  Obes Surg       Date:  2012-02-01       Impact factor: 4.129

2.  Fatal venous thromboembolism associated with different combined oral contraceptives: a study of incidences and potential biases in spontaneous reporting.

Authors:  Karin Hedenmalm; Eva Samuelsson
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Risk factors for venous thromboembolism in endometrial cancer.

Authors:  S Pin; J Mateshaytis; S Ghosh; E Batuyong; J C Easaw
Journal:  Curr Oncol       Date:  2020-08-01       Impact factor: 3.677

4.  Pharmacodynamics and pharmacokinetics of oral contraceptives co-administered with alosetron (Lotronex).

Authors:  Kevin Koch; Corinne Campanella; Charlotte A Baidoo; Janet A Manzo; Vanessa Z Ameen; Kathryn E E Kersey
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

5.  Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-up.

Authors:  Nazim Isma; Juan Merlo; Henrik Ohlsson; Peter J Svensson; Bengt Lindblad; Anders Gottsäter
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

6.  Chronic granulomatous disease as a risk factor for autoimmune disease.

Authors:  Suk See De Ravin; Nora Naumann; Edward W Cowen; Julia Friend; Dianne Hilligoss; Martha Marquesen; James E Balow; Karyl S Barron; Maria L Turner; John I Gallin; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2008-09-26       Impact factor: 10.793

7.  Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2).

Authors:  Petter Quist-Paulsen; Inger Anne Naess; Suzanne C Cannegieter; Pål R Romundstad; Sverre C Christiansen; Frits R Rosendaal; Jens Hammerstrøm
Journal:  Haematologica       Date:  2009-08-27       Impact factor: 9.941

8.  Unexpected complication of massive intraoperative pulmonary embolism following elective sigmoidectomy in the supine position.

Authors:  Ekaterini N Amaniti; Georgia G Tsaousi; Nektarios A Kteniadakis; Panagiota G Maidatsi; Dimitrios G Vasilakos
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

9.  Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery : Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety.

Authors:  Ola E Dahl; Bengt I Eriksson; Giancarlo Agnelli; Alexander T Cohen; Patrick Mouret; Nadia Rosencher; Seva Panfilov; Anders Bylock; Magnus Andersson
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

Review 10.  The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.

Authors:  Andrew D Blann; Chee W Khoo
Journal:  Vasc Health Risk Manag       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.